CLINICAL_TRIALS
trial_result
· 2015-07-23
Clinical Trial Update: Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone [Phase 1, Phase 2]
Summary
A Phase 1/Phase 2 study evaluating sorafenib with palliative radiotherapy for renal cell carcinoma with bone metastases has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED